Tuesday, April 21, 2020 3:19:24 PM
213M shares currently issued.
Company has previously projected 525M test kits sold in first year, with most sales dependent on a home test test for anti-bodies. 2nd test kit in development. Given the interest in the first kit from companies, those figures might get changed Thursday.
They expect selling one kit for 6.95 and the other for 10.95 I believe, but we don't have breakout.
You can do the math. It they hit target goals 525M test kits at $8/avg is $4.2B in revenue would make this a $20/share stock on 1/1 rev per share alone. Put that at 6x-12x revenue and you get another price.
So, let's say they are extremely over optimistic about their manufacturing and sales capacity. Let's throw out 5M kits per month over 12 months or 60M kits sold at $8/kit or 480M in rev for first year of sales / 215M shares or revenue of over $2/share. What would you expect the actual stock share price to be?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM